Evaluation of a shorter methionine loading test

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 9, 2004, Pages 1027-1031

  de Jonge, Robert ^a   Griffioen, Pieter H ^a   van Zelst, Bertrand ^a   Montserrate Brouns, R ^a   Visser, Willy ^a   Lindemans, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Homocysteine; Methionine loading test; Methylenetetrahydrofolate reductase (MTHFR); Mutation

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CREATININE; CYANOCOBALAMIN; CYSTEINE; EDETIC ACID; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE; THREONINE;

ACCURACY; ADULT; ARTICLE; BODY WEIGHT; CLASSIFICATION; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; LINEAR REGRESSION ANALYSIS; LOADING TEST; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN METHYLATION; SCORING SYSTEM; STATISTICAL ANALYSIS; VALIDATION PROCESS; WILD TYPE;

ADMINISTRATION, ORAL; ADULT; CARDIOVASCULAR DISEASES; CHELATING AGENTS; EDETIC ACID; FASTING; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LINEAR MODELS; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; TIME FACTORS;

EID: 4744370391     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.207     Document Type: Article

References (22)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 1995;274:1049-57.
2. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. J Am Med Assoc 1997;277:1775-81.
3. Collaboration THS. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002;288:2015-22.
4. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM. Effect of homocysteine-lowering therapy with folic acid, vitamin B(12), and vitamin B(6) on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. J Am Med Assoc 2002;288:973-9.
5. Ray JG, Laskin CA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: a systematic review. Placenta 1999;20:519-29.
6. Bostom AG, Jacques PF, Nadeau MR, Williams RR, Ellison RC, Selhub J. Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study. Atherosclerosis 1995;116:147-51.
7. van der Griend R, Haas FJ, Duran M, Biesma DH, Meuwissen OJ, Banga JD. Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med 1998;132:67-72.
8. Bostom AG, Roubenoff R, Dellaripa P, Nadeau MR, Sutherland P, Wilson PW, et al. Validation of abbreviated oral methionine-loading test. Clin Chem 1995;41:948-9.
9. Sassi S, Cosmi B, Palareti G, Legnani C, Grossi G, Musolesi S, et al. Influence of age, sex and vitamin status on fasting and post-methionine load plasma homocysteine levels. Haematologica 2002;87:957-64.
10. de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, et al. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease. Arterioscler Thromb Vasc Biol 1999; 19:1316-24.
11. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chrdmatogr 1987;422:43-52.
12. Schrijver J, Speek AJ, Schreurs WH. Semi-automated fluorometric determination of pyridoxal-5′-phosphate (vitamin B6) in whole blood by high-performance liquid chromatography (HPLC). Int J Vitam Nutr Res 1981;51:216-22.
13. Gregory JF 3rd. Determination of pyridoxal 5′-phosphate as the semicarbazone derivative using high-performance liquid chromatography. Anal Biochem 1980;102:374-9.
14. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
15. Snedecor GW, Cochran WG. Statistical methods, 7th ed. Ames, IA: Iowa State University Press, 1995.
16. Ubbink JB, Becker PJ, Delport R, Bester M, Riezier R, Vermaak WJ. Variability of post-methionine load plasma homocysteine assays. Clin Chim Acta 2003;330:111-9.
17. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998; 98:2520-6.
18. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C→ T polymorphism and risk of coronary heart disease: a meta-analysis. J Am Med Assoc 2002;288:2023-31.
19. Verhoef P, Kok FJ, Kluijtmans LA, Blom HJ, Refsum H, Ueland PM, et al. The 677C→ T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 1997;132: 105-13.
20. Tsai MY, Welge BG, Hanson NQ, Bignell MK, Vessey J, Schwichtenberg K, et al. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis 1999;143: 163-70.
21. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 2001;47:661-6.
22. Olivieri O, Friso S, Trabetti E, Girelli D, Pizzolo F, Faccini G, et al. Homocysteine and atheromatous renal artery stenosis. Clin Exp Med 2001;1:211-8.